What’s Going On With Bitcoin Mining Stock CleanSpark?

CleanSpark Inc (NASDAQ: CLSK) shares are trading lower.

CleanSpark Inc (NASDAQ:CLSK) shares are trading lower. The company on Monday announced the purchase of up to 160,000 Bitmain miners.

What To Know: CleanSpark said it entered into a strategic agreement to purchase up to 160,000 Bitmain S21 Bitcoin miners, representing the equivalent of 32 exahashes per second (EH/s).

CleanSpark initially purchased 60,000 units, which are expected to be delivered between April and June. The purchase price for the first 60,000 units is $16.10 per terahash, for a total of $193.2 million.

The agreement also includes a strategic call option to purchase an additional 100,000 machines at a fixed price of $16 per terahash until the end of the year.

If the full option is exercised, CleanSpark’s hashrate is expected to increase from 10 EH/s to approximately 50 EH/s once all machines are deployed.

“This strategic agreement enhances our operational efficiency, provides massive optionality, and positions us to maximize opportunities that we expect on the horizon,” said Zachary Bradford, CEO of CleanSpark.

“We are ready to expand into the next bull market without the need to worry about an increase in machine prices, since the call purchase option acts as a hedge to this risk.”

CleanSpark noted that the S21 mining machines are the most efficient on the market.

See Also: Bitcoin Adoption Spreads: Japanese Marketplace, Honduran Economic Zone Integrate

CLSK Price Action: CleanSpark shares were down 4.41% at $9.72 at the time of publication, according to Benzinga Pro.

Photo: Eivind Pedersen from Pixabay.

Total
0
Shares
Related Posts
Read More

Edwards Lifesciences Presents 5-Year Follow Up Data From PARTNER Trials Showing Clinical Outcomes For Female And Small Annulus Patients With Transcatheter Aortic Valve Replacement At The New York Valves 2024: The Structural Heart Summit

Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through

EW

Read More

Prophase Labs’ Prophase Labs Will Acquiring New Equipment Which Is Expected To Double Its Current Capacity For Pouch Packaging By Q2 Of 2023. Pharmaloz Is Also Planning For Expansion Of Its Lozenge Manufacturing Business

Altogether, these expansion initiatives are expected to lead to a 200% increase in capacity for 2024 as compared to 2022. It is currently expected that the Pharmaloz expansion will be funded entirely from

PRPH